Oral COVID-19 Vaccine Being Tested
THURSDAY, April 8, 2021 -- California researchers are testing whether an oral vaccine offers similar or better protection than current COVID-19 shots.
The capsule-delivered vaccine under development at the Chan Soon-Shiong Research Institute in El Segundo is being tested in healthy volunteers, CBS News reported.
Existing vaccines promote production of antibodies to the spike protein on the surface of the coronavirus that causes COVID-19, but the ImmunityBio T cell oral vaccine targets the globe in the middle of the virus, a part that is less prone to mutation, according to scientists. "And the value of doing so is that we generate killer T cells," ImmunityBio founder and Executive Chairman Patrick Soon-Shiong, M.D., told CBS News.
The ImmunityBio researchers believe they may be able to create long-term protection by generating both antibodies and killer T cells.
© 2021 HealthDay. All rights reserved.
Posted: April 2021
Further Support and Information on COVID-19
Read this next
MONDAY, April 19, 2021 -- The official global COVID-19 death toll surpassed 3 million this weekend, according to Johns Hopkins University data. But the actual number of people...
MONDAY, April 19, 2021 -- Moderna says a third booster shot for its two-dose COVID-19 vaccine will be available in the United States by the fall. The announcement was made by...
MONDAY, April 19, 2021 -- An indefinite extension on wearing masks and social distancing in all businesses is being considered by the administrator of the Oregon Department of...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.